论文部分内容阅读
Fhsequinan（manoplax）是一种新的对动、静脉均有扩张作用的口服剂。本文作者在一组扩张型心肌病心衰患者的标准治疗中加入小剂量flosequinan，根据血液动力学测定了解该药的扩血管作用对左室收缩期及舒张期作功的影响。1方法10例男性扩张型心肌病（平均年龄53土10岁），均为
Fhsequinan (manoplax) is a new oral agent that has a spreading action on both the veins and veins. The authors add a small dose of flosequinan to standard therapy in patients with heart failure with dilated cardiomyopathy to determine the effect of the vasodilator effect on left ventricular systolic and diastolic work based on hemodynamic measures. A method of 10 cases of male dilated cardiomyopathy (mean age 53 soil 10 years old), were